Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-08-18

AUTHORS

Haruo Nakamura, Kyoichi Mizuno, for the MEGA Study Group

ABSTRACT

BackgroundThe prognosis for hyper-high-density lipoprotein (HDL) cholesterolemic patients has not been fully elucidated. We conducted a post hoc analysis of MEGA study data to investigate prospectively the incidence of cardiovascular events and cancer in hyper-HDL cholesterolemic patients.MethodsA total of 7832 patients with mild hypercholesterolemia were randomly allocated to either the National Cholesterol Education Program step 1 diet alone (n = 3966) or the diet plus pravastatin (n = 3866) and followed for 5 years. The incidences of coronary heart disease (CHD), CHD plus cerebral infarction (CI), cardiovascular disease (CVD), and cancer were calculated using the Cox proportional hazards model according to the level of HDL cholesterol (HDL-C).ResultsCHD incidence was lower in patients with HDL-C >60–90 mg/dL (-52%, p = 0.0018) and HDL-C > 90 mg/dL (-46%, p = 0.4007) than in patients with HDL-C ≤ 60 mg/dL. The incidences of CHD, CHD plus CI, and CVD were significantly lower in patients with HDL-C >60–90 mg/dL than in those with HDL-C ≤ 60 mg/dL in both diet-alone and diet-plus-pravastatin groups. Cancer incidence was not increased in patients with HDL-C >60–90 mg/dL.ConclusionPatients not receiving statin therapy should aim for a target HDL-C of between 60 and 90 mg/dL to achieve a significant reduction in CHD without the occurrence of adverse events.Trial registrationClinical trials.gov NCT00211705. More... »

PAGES

133

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1476-511x-13-133

DOI

http://dx.doi.org/10.1186/1476-511x-13-133

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045636567

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25135178


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cerebral Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, HDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypercholesterolemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Mitsukoshi Health and Welfare Foundation, 1-24-1, Nishi-shinjuku, 160-0023, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.490945.5", 
          "name": [
            "Mitsukoshi Health and Welfare Foundation, 1-24-1, Nishi-shinjuku, 160-0023, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Haruo", 
        "id": "sg:person.015301342162.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015301342162.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Nippon Medical School, 1-5 Sendagi 1-chome, 113-8603, Bunkyo-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410821.e", 
          "name": [
            "Department of Medicine, Nippon Medical School, 1-5 Sendagi 1-chome, 113-8603, Bunkyo-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizuno", 
        "givenName": "Kyoichi", 
        "id": "sg:person.01224612517.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224612517.39"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "for the MEGA Study Group", 
        "type": "Person"
      }
    ], 
    "datePublished": "2014-08-18", 
    "datePublishedReg": "2014-08-18", 
    "description": "BackgroundThe prognosis for hyper-high-density lipoprotein (HDL) cholesterolemic patients has not been fully elucidated. We conducted a post hoc analysis of MEGA study data to investigate prospectively the incidence of cardiovascular events and cancer in hyper-HDL cholesterolemic patients.MethodsA total of 7832 patients with mild hypercholesterolemia were randomly allocated to either the National Cholesterol Education Program step 1 diet alone (n = 3966) or the diet plus pravastatin (n = 3866) and followed for 5\u00a0years. The incidences of coronary heart disease (CHD), CHD plus cerebral infarction (CI), cardiovascular disease (CVD), and cancer were calculated using the Cox proportional hazards model according to the level of HDL cholesterol (HDL-C).ResultsCHD incidence was lower in patients with HDL-C >60\u201390 mg/dL (-52%, p = 0.0018) and HDL-C > 90 mg/dL (-46%, p = 0.4007) than in patients with HDL-C \u2264 60 mg/dL. The incidences of CHD, CHD plus CI, and CVD were significantly lower in patients with HDL-C >60\u201390 mg/dL than in those with HDL-C \u2264 60 mg/dL in both diet-alone and diet-plus-pravastatin groups. Cancer incidence was not increased in patients with HDL-C >60\u201390 mg/dL.ConclusionPatients not receiving statin therapy should aim for a target HDL-C of between 60 and 90\u00a0mg/dL to achieve a significant reduction in CHD without the occurrence of adverse events.Trial registrationClinical trials.gov NCT00211705.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1476-511x-13-133", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031029", 
        "issn": [
          "1476-511X"
        ], 
        "name": "Lipids in Health and Disease", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "coronary heart disease", 
      "cerebral infarction", 
      "cardiovascular disease", 
      "National Cholesterol Education Program Step 1 diet", 
      "incidence of CHD", 
      "Step 1 diet", 
      "Cox proportional hazards", 
      "MEGA study data", 
      "pravastatin group", 
      "cardiovascular events", 
      "mild hypercholesterolemia", 
      "statin therapy", 
      "adverse events", 
      "HDL cholesterol", 
      "cancer events", 
      "heart disease", 
      "cancer incidence", 
      "patients", 
      "MEGA study", 
      "proportional hazards", 
      "HDL", 
      "incidence", 
      "significant reduction", 
      "diet", 
      "cancer", 
      "disease", 
      "target HDL", 
      "study data", 
      "ConclusionPatients", 
      "infarction", 
      "hypercholesterolemia", 
      "prognosis", 
      "pravastatin", 
      "therapy", 
      "dl", 
      "cholesterol", 
      "events", 
      "total", 
      "group", 
      "years", 
      "levels", 
      "study", 
      "occurrence", 
      "reduction", 
      "analysis", 
      "hazards", 
      "data"
    ], 
    "name": "Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study", 
    "pagination": "133", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045636567"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1476-511x-13-133"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25135178"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1476-511x-13-133", 
      "https://app.dimensions.ai/details/publication/pub.1045636567"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_649.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1476-511x-13-133"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1476-511x-13-133'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1476-511x-13-133'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1476-511x-13-133'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1476-511x-13-133'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      20 PREDICATES      85 URIs      77 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1476-511x-13-133 schema:about N4943f2c9fe4849488af8fc9416d2f848
2 N4ca3c42e39904691b6fb395453e13b23
3 N5d92859cbab145c99c9a15d0604caeef
4 N74eff7707ee24bc0ad3974a53cf8c741
5 N786639a21ccd45c6a0fd48f956f57b49
6 N80617cb6bf7b49189cfca7e8eb55a2d0
7 Nc195578b005444f680b208ec719cc85f
8 Nce38b06af3b64977a05ea7e481b55dee
9 Ndebdb79d9f9d4447821a06f240d6a654
10 Nebdfffabe9fc400eb600408aeddc71ea
11 Nec913e725ce644b7aa41c92eeab9757a
12 Necb9c93908654d4ababc5ebb48fe7def
13 Nf0cbcb98cf08444f93bf34fb946a8d7a
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N14f1badfaa8e4f68baeb7f2642c0b13c
17 schema:datePublished 2014-08-18
18 schema:datePublishedReg 2014-08-18
19 schema:description BackgroundThe prognosis for hyper-high-density lipoprotein (HDL) cholesterolemic patients has not been fully elucidated. We conducted a post hoc analysis of MEGA study data to investigate prospectively the incidence of cardiovascular events and cancer in hyper-HDL cholesterolemic patients.MethodsA total of 7832 patients with mild hypercholesterolemia were randomly allocated to either the National Cholesterol Education Program step 1 diet alone (n = 3966) or the diet plus pravastatin (n = 3866) and followed for 5 years. The incidences of coronary heart disease (CHD), CHD plus cerebral infarction (CI), cardiovascular disease (CVD), and cancer were calculated using the Cox proportional hazards model according to the level of HDL cholesterol (HDL-C).ResultsCHD incidence was lower in patients with HDL-C >60–90 mg/dL (-52%, p = 0.0018) and HDL-C > 90 mg/dL (-46%, p = 0.4007) than in patients with HDL-C ≤ 60 mg/dL. The incidences of CHD, CHD plus CI, and CVD were significantly lower in patients with HDL-C >60–90 mg/dL than in those with HDL-C ≤ 60 mg/dL in both diet-alone and diet-plus-pravastatin groups. Cancer incidence was not increased in patients with HDL-C >60–90 mg/dL.ConclusionPatients not receiving statin therapy should aim for a target HDL-C of between 60 and 90 mg/dL to achieve a significant reduction in CHD without the occurrence of adverse events.Trial registrationClinical trials.gov NCT00211705.
20 schema:genre article
21 schema:isAccessibleForFree true
22 schema:isPartOf N8fff1bfafd6c423ca1acafafa5715496
23 Ne86aebfa03d54937826993b089fb9318
24 sg:journal.1031029
25 schema:keywords ConclusionPatients
26 Cox proportional hazards
27 HDL
28 HDL cholesterol
29 MEGA study
30 MEGA study data
31 National Cholesterol Education Program Step 1 diet
32 Step 1 diet
33 adverse events
34 analysis
35 cancer
36 cancer events
37 cancer incidence
38 cardiovascular disease
39 cardiovascular events
40 cerebral infarction
41 cholesterol
42 coronary heart disease
43 data
44 diet
45 disease
46 dl
47 events
48 group
49 hazards
50 heart disease
51 hypercholesterolemia
52 incidence
53 incidence of CHD
54 infarction
55 levels
56 mild hypercholesterolemia
57 occurrence
58 patients
59 pravastatin
60 pravastatin group
61 prognosis
62 proportional hazards
63 reduction
64 significant reduction
65 statin therapy
66 study
67 study data
68 target HDL
69 therapy
70 total
71 years
72 schema:name Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study
73 schema:pagination 133
74 schema:productId N6ee213b2e04244b6af5b5d5b43ed2f9c
75 Na22e3c27a2c647cb8e4a07cd84fe02fc
76 Nb767906d72e64b3c9afdc66372befb49
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045636567
78 https://doi.org/10.1186/1476-511x-13-133
79 schema:sdDatePublished 2022-09-02T15:57
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher Nc737d5d2b8e248eca26e93fe15319e47
82 schema:url https://doi.org/10.1186/1476-511x-13-133
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N14f1badfaa8e4f68baeb7f2642c0b13c rdf:first sg:person.015301342162.18
87 rdf:rest Ncde263daa73846de8ff21479e65c5d97
88 N4943f2c9fe4849488af8fc9416d2f848 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Male
90 rdf:type schema:DefinedTerm
91 N4ca3c42e39904691b6fb395453e13b23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Randomized Controlled Trials as Topic
93 rdf:type schema:DefinedTerm
94 N5d92859cbab145c99c9a15d0604caeef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Female
96 rdf:type schema:DefinedTerm
97 N6ee213b2e04244b6af5b5d5b43ed2f9c schema:name doi
98 schema:value 10.1186/1476-511x-13-133
99 rdf:type schema:PropertyValue
100 N71624afb38ff4c9cb8b4823d58184685 schema:familyName for the MEGA Study Group
101 rdf:type schema:Person
102 N74eff7707ee24bc0ad3974a53cf8c741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N786639a21ccd45c6a0fd48f956f57b49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Middle Aged
107 rdf:type schema:DefinedTerm
108 N80617cb6bf7b49189cfca7e8eb55a2d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Proportional Hazards Models
110 rdf:type schema:DefinedTerm
111 N8fff1bfafd6c423ca1acafafa5715496 schema:issueNumber 1
112 rdf:type schema:PublicationIssue
113 Na22e3c27a2c647cb8e4a07cd84fe02fc schema:name dimensions_id
114 schema:value pub.1045636567
115 rdf:type schema:PropertyValue
116 Nb767906d72e64b3c9afdc66372befb49 schema:name pubmed_id
117 schema:value 25135178
118 rdf:type schema:PropertyValue
119 Nc195578b005444f680b208ec719cc85f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cholesterol, HDL
121 rdf:type schema:DefinedTerm
122 Nc737d5d2b8e248eca26e93fe15319e47 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 Ncde263daa73846de8ff21479e65c5d97 rdf:first sg:person.01224612517.39
125 rdf:rest Neaa8689d833e416aa1d60c169c0f2c1c
126 Nce38b06af3b64977a05ea7e481b55dee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Neoplasms
128 rdf:type schema:DefinedTerm
129 Ndebdb79d9f9d4447821a06f240d6a654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Hypercholesterolemia
131 rdf:type schema:DefinedTerm
132 Ne86aebfa03d54937826993b089fb9318 schema:volumeNumber 13
133 rdf:type schema:PublicationVolume
134 Neaa8689d833e416aa1d60c169c0f2c1c rdf:first N71624afb38ff4c9cb8b4823d58184685
135 rdf:rest rdf:nil
136 Nebdfffabe9fc400eb600408aeddc71ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Coronary Disease
138 rdf:type schema:DefinedTerm
139 Nec913e725ce644b7aa41c92eeab9757a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Follow-Up Studies
141 rdf:type schema:DefinedTerm
142 Necb9c93908654d4ababc5ebb48fe7def schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Incidence
144 rdf:type schema:DefinedTerm
145 Nf0cbcb98cf08444f93bf34fb946a8d7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Cerebral Infarction
147 rdf:type schema:DefinedTerm
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
152 schema:name Cardiorespiratory Medicine and Haematology
153 rdf:type schema:DefinedTerm
154 sg:journal.1031029 schema:issn 1476-511X
155 schema:name Lipids in Health and Disease
156 schema:publisher Springer Nature
157 rdf:type schema:Periodical
158 sg:person.01224612517.39 schema:affiliation grid-institutes:grid.410821.e
159 schema:familyName Mizuno
160 schema:givenName Kyoichi
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224612517.39
162 rdf:type schema:Person
163 sg:person.015301342162.18 schema:affiliation grid-institutes:grid.490945.5
164 schema:familyName Nakamura
165 schema:givenName Haruo
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015301342162.18
167 rdf:type schema:Person
168 grid-institutes:grid.410821.e schema:alternateName Department of Medicine, Nippon Medical School, 1-5 Sendagi 1-chome, 113-8603, Bunkyo-ku, Tokyo, Japan
169 schema:name Department of Medicine, Nippon Medical School, 1-5 Sendagi 1-chome, 113-8603, Bunkyo-ku, Tokyo, Japan
170 rdf:type schema:Organization
171 grid-institutes:grid.490945.5 schema:alternateName Mitsukoshi Health and Welfare Foundation, 1-24-1, Nishi-shinjuku, 160-0023, Tokyo, Japan
172 schema:name Mitsukoshi Health and Welfare Foundation, 1-24-1, Nishi-shinjuku, 160-0023, Tokyo, Japan
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...